Caribou Biosciences, Inc. Logo

Caribou Biosciences, Inc.

Uses CRISPR genome editing to create off-the-shelf CAR-T cell therapies for cancer.

CRBU | NDAQ

Overview

Corporate Details

ISIN(s):
US1420381089
LEI:
Country:
United States of America
Address:
2929 7TH STREET, SUITE 105, 94710 BERKELEY
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Caribou Biosciences, Inc. is a clinical-stage biopharmaceutical company developing transformative, genome-edited cell therapies. A leader in the CRISPR field, the company utilizes its proprietary chRDNA (CRISPR hybrid RNA-DNA) technology to engineer complex, multiplex edits with high precision and specificity. Its primary focus is on creating allogeneic, or "off-the-shelf," CAR-T cell therapies for patients with hematologic malignancies and other devastating diseases. A key component of its strategy is "armoring" these therapies through genome editing techniques, such as immune cloaking and checkpoint disruption, to enhance their persistence and anti-tumor activity. The company was co-founded by CRISPR pioneer and 2020 Nobel laureate Jennifer Doudna.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Caribou Biosciences, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Caribou Biosciences, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Caribou Biosciences, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Bayer AG Logo
A life science firm providing pharmaceuticals, consumer health, and crop science solutions.
Germany BAY
Beam Therapeutics Inc. Logo
Developing precision genetic medicines using base editing to provide cures for serious diseases.
United States of America BEAM
BELITE BIO, INC Logo
Developing novel oral therapies for retinal degenerative eye diseases like GA and Stargardt disease.
United States of America BLTE
Benchmark Holdings Plc Logo
Aquaculture biotech providing nutrition and health solutions for sustainable farming.
United Kingdom BMK
Benitec Biopharma Inc. Logo
Develops ddRNAi gene therapies to silence genes causing chronic, life-threatening diseases.
United States of America BNTC
BeOne Medicines Ltd. Logo
Develops innovative and accessible cancer treatments for patients worldwide.
United States of America ONC
BGM Group Ltd. Logo
A pharma holding co. making APIs & TCM derivatives via bio-fermentation and extraction.
United States of America BGM
Bicara Therapeutics Inc. Logo
Developing first-in-class, dual-action bifunctional therapies for solid tumor patients.
United States of America BCAX
BICYCLE THERAPEUTICS PLC Logo
Developing novel bicyclic peptide medicines to precisely target hard-to-treat cancers.
United States of America BCYC
BIFIDO. Co. Ltd Logo
Biotech firm specializing in microbiome R&D for functional foods and cosmeceuticals.
South Korea 238200

Talk to a Data Expert

Have a question? We'll get back to you promptly.